BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections.
Bloodstream infections are mostly diagnosed by blood culture tests and molecular tests. Commercially available tests are SepsiTest, SeptiFast, MagicPlex, VYOO, and PLEX-ID. The global bloodstream infection testing market is driven by the growing incidence and prevalence of burn/wounds cases, HIV, pneumonia, pyelonephritis, and cancer. Additionally, awareness about hygiene, diagnosis rate, unhealthy lifestyle, and increase in geriatric population are the potential factors for the market growth. On the other hand, rigid regulatory scenario regarding diagnosis procedures, high diagnosis cost, and lack of medical reimbursement may hinder the growth of the market during the forecast period. Innovations, R&D investments, mergers and acquisitions among the key vendors are the dynamics for the bloodstream infection testing market to progress.  

Market Analysis and Insights: Global Blood Stream Infection Testing Market
The global Blood Stream Infection Testing market size is projected to reach US$ 5862.7 million by 2027, from US$ 3679.1 million in 2020, at a CAGR of 6.8% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Blood Stream Infection Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Blood Stream Infection Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Blood Stream Infection Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Blood Stream Infection Testing market.

Global Blood Stream Infection Testing Scope and Market Size
Blood Stream Infection Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Blood Stream Infection Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Conventional Blood Culture Tests
PCR Methods
Nucleic Acid Testing
Mass Spectroscopy
Point of Care Testing

Segment by Application
Hospitals
Independent Diagnostic Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
BD
bioMérieux
Cepheid
Roche Diagnostics
IRIDICA
Bruker
Nanosphere
Siemens
AdvanDX